Published in Brain on September 30, 2016
Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study. PLoS Med (2017) 0.76
Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery. PLoS Med (2017) 0.75
Population-based analysis of pathological correlates of dementia in the oldest old. Ann Clin Transl Neurol (2017) 0.75
Applying fluid biomarkers to Alzheimer's disease. Am J Physiol Cell Physiol (2017) 0.75
Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study. Lancet Neurol (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging (1997) 10.81
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun (2006) 10.69
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging (2002) 6.18
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol (2007) 5.98
The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology (2005) 5.64
The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol (2009) 4.96
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc (2005) 3.68
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology (2006) 3.00
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol (2008) 2.96
The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology (2015) 2.81
Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol (2013) 2.78
Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol (2009) 2.76
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis (2009) 2.54
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res (2007) 2.38
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology (2008) 2.01
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol (2009) 2.01
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol (2008) 1.53
TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol (2014) 1.47
TDP-43 in aging and Alzheimer's disease - a review. Int J Clin Exp Pathol (2011) 1.46
TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol (2013) 1.37
Staging TDP-43 pathology in Alzheimer's disease. Acta Neuropathol (2013) 1.36
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol (2011) 1.32
Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke (2011) 1.30
Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol (2010) 1.29
Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain (2011) 1.29
Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav (2012) 1.20
TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathol (2010) 1.19
Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Neuropathology (2009) 1.15
Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis (2013) 1.03
Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol (2015) 1.03
Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology (2006) 0.98
Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol (2011) 0.97
TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol (2013) 0.95
Updated TDP-43 in Alzheimer's disease staging scheme. Acta Neuropathol (2016) 0.95
On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog Neurobiol (2011) 0.95
Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) (2014) 0.92
TAR-DNA binding protein-43 and alterations in the hippocampus. J Neural Transm (Vienna) (2011) 0.91
TDP-43 pathology in the population: prevalence and associations with dementia and age. J Alzheimers Dis (2014) 0.90
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol (2016) 0.83
Unlocking the mysteries of TDP-43. Neurology (2015) 0.81
TDP-43: a new player on the AD field? Exp Neurol (2012) 0.80
Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons. J Neuropathol Exp Neurol (2016) 0.78
The Role of TDP-43 in Alzheimer's Disease. Mol Neurobiol (2015) 0.76